Search

March 05, 2024, Business Insurance
Alabama Embryo Ruling May Increase Med Mal Risks
Robert White, President of The Doctors Company and TDC Group, discusses the potential impacts the recent IVF ruling in Alabama will have on healthcare professionals.

March 30, 2022, Medical Economics
Why Malpractice Insurance Premiums Are Rising
Robert E. White, Jr., Chief Operating Officer of The Doctors Company and TDC Group, explains what’s behind recent increases in physicians’ malpractice insurance rates.

The Doctors Company Assists Members Impacted by Hurricanes Helene and Milton
Due to disruption to member medical practices from Hurricanes Helene and Milton and consistent with direction from state insurance regulation offices, The Doctors Company will adjust policy cancellation and premium installment due dates for affected members. Premium due dates have generally been extended in Florida, Georgia, North Carolina, South Carolina, and Tennessee.

Professional Education
Module 2: Alternatives to Opioids for Pain (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will be refamiliarized utilizing the CDC Guidelines for prescribing opioids. You will also be encouraged to utilize nonpharmacological and pharmacological alternatives to opioids. Lastly, assess your effectiveness and use of the Enhanced Recovery After Surgery (ERAS) program. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.

Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.

Jan 30, 2025
Off-Label Use: Patient Safety Implications
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, Part of TDC Group
Once authorized, a drug product may be prescribed by a licensed healthcare practitioner for any use deemed appropriate based on the practitioner’s professional opinion. The governing standard is what other similarly trained practitioners would do—not what the manufacturer of the medication or product recommends.

Stay in the Know

Our e-newsletters feature timely articles, videos, and guides on a range of patient safety topics.

The Doctor’s Practice

Medical Icon Clipart Subscribe

The Dentist’s Advocate

Tooth Clipart Subscribe

The Practitioner

Man and Two Women Doctors Clipart Subscribe